VanEck Associates’s Tenet Healthcare THC Stock Holding History

VanEck Associates’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.15M	Buy	16,814 +13,749	+449%	+$2.53M	﹤0.01%	946
2026 Q1	$578K	Sell	3,065 -410	-12%	-$86.4K	﹤0.01%	1159
2025 Q4	$691K	Buy	3,475 +166	+5%	+$33.5K	﹤0.01%	1130
2025 Q3	$672K	Sell	3,309 -1,820	-35%	-$323K	﹤0.01%	1142
2025 Q2	$903K	Sell	5,129 -1	-0%	-$151	﹤0.01%	1076
2025 Q1	$690K	Buy	5,130 +868	+20%	+$114K	﹤0.01%	1100
2024 Q4	$538K	Sell	4,262 -194	-4%	-$28.8K	﹤0.01%	1122
2024 Q3	$702K	Sell	4,456 -3,163	-42%	-$478K	﹤0.01%	1049
2024 Q2	$1.01M	Sell	7,619 -136	-2%	-$16.4K	﹤0.01%	994
2024 Q1	$815K	Sell	7,755 -1,707	-18%	-$153K	﹤0.01%	1004
2023 Q4	$715K	Sell	9,462 -1,606	-15%	-$102K	﹤0.01%	1002
2023 Q3	$729K	Buy	+11,068	New	+$827K	﹤0.01%	976

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

VanEck Associates's THC Position: Q2 2026 in Review

VanEck Associates increased its Tenet Healthcare (THC) stake by 449% in Q2 2026, buying an estimated $2.53M and bringing the position to 16,814 shares worth $3.15M. The position accounts for ﹤0.01% of the portfolio, ranked #946.

VanEck Associates first reported a position in THC in Q3 2023 and has held it in 12 quarters since. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

VanEck Associates held 16,814 shares of Tenet Healthcare worth $3.15M as of Q2 2026.
VanEck Associates bought 13,749 Tenet Healthcare shares in Q2 2026, an estimated $2.53M.
Tenet Healthcare made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #946 holding.
VanEck Associates first reported a position in Tenet Healthcare in Q3 2023 and has held it in 12 quarters since.
679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.